EPA announced the release of $2.3M in SBIR funding to 21 companies, highlighting AAPlasma's efforts in destroying antibiotic-resistant (AR) bacteria and AR genes in wastewater streams from hospitals, food processing facilities, etc.

Following the EPA release, we were mentioned in the blog post by the former PA DEP Secretary Dave Hess.

AAPlasma continues its R&D efforts to de-risk cold plasma-based water treatment technologies.